Investors Can Find Comfort In Youcare Pharmaceutical Group's (SHSE:688658) Earnings Quality

The market for Youcare Pharmaceutical Group Co., Ltd.'s (SHSE:688658) shares didn't move much after it posted weak earnings recently. Our analysis suggests that while the profits are soft, the foundations of the business are strong.

Check out our latest analysis for Youcare Pharmaceutical Group

How Do Unusual Items Influence Profit?

For anyone who wants to understand Youcare Pharmaceutical Group's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by CN¥28m due to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. If Youcare Pharmaceutical Group doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Youcare Pharmaceutical Group's Profit Performance

Because unusual items detracted from Youcare Pharmaceutical Group's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Because of this, we think Youcare Pharmaceutical Group's earnings potential is at least as good as it seems, and maybe even better! On the other hand, its EPS actually shrunk in the last twelve months. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. Every company has risks, and we've spotted 4 warning signs for Youcare Pharmaceutical Group (of which 1 is a bit concerning!) you should know about.

Today we've zoomed in on a single data point to better understand the nature of Youcare Pharmaceutical Group's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.